Paper Details 
Original Abstract of the Article :
Patients treated with oral anticancer agents (e.g., kinase inhibitors) are a high-risk population for medication errors due to, for example, polymedication, age, and limited adherence. Systematic evaluations regarding frequencies and causes of medication errors and resulting harm are lacking. Our pr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/cpt.2338

データ提供:米国国立医学図書館(NLM)

Medication Errors: A Hidden Threat in Oral Anticancer Treatment

Oral anticancer agents, a cornerstone of modern cancer treatment, offer patients convenience and flexibility. However, this study delves into a critical concern associated with these medications: medication errors. The researchers investigate the frequency, causes, and consequences of medication errors in patients receiving oral anticancer agents, highlighting the need for improved patient safety measures.

The study revealed a significant rate of medication errors in patients receiving oral anticancer agents, with an average of 1.7 errors per patient. The authors identified various contributing factors, including polypharmacy, patient age, and limited adherence. They also emphasized the importance of comprehensive medication reviews conducted by clinical pharmacists to identify and mitigate potential errors. The findings highlight the crucial role of pharmacists in ensuring patient safety during oral anticancer therapy.

Protecting Patients from Medication Errors

This study underscores the importance of implementing comprehensive strategies to prevent medication errors in patients receiving oral anticancer agents. It highlights the critical role of clinical pharmacists in ensuring safe and effective medication management. The findings call for increased awareness, improved communication, and the development of robust clinical decision support systems to minimize the risk of medication errors and optimize patient outcomes.

Dr. Camel's Conclusion

This study reminds us that the desert of healthcare is not without its treacherous paths and hidden dangers. The authors' findings highlight the potential for medication errors, emphasizing the importance of vigilance and proactive measures to protect patients. We must work together to create a safer and more effective healthcare system, ensuring that all patients receive the best possible care.

Date :
  1. Date Completed 2021-10-11
  2. Date Revised 2021-10-11
Further Info :

Pubmed ID

34118065

DOI: Digital Object Identifier

10.1002/cpt.2338

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.